Trial Details

UNKNOWN
Basic Information
Clinical ID c4120
Identifier NCT01024647
Trial Title Optimizing Cimzia in Crohn's Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions BIOLOGICAL: certolizumab pegol|BIOLOGICAL: certolizumab pegol|BIOLOGICAL: certolizumab pegol|BIOLOGICAL: certolizumab pegol
Participant Information
Sponsor Atlanta Gastroenterology Associates
City Atlanta
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2009-12
Primary Completion Date 2013-05
Completion Date 2013-05